These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3913640)

  • 1. Metabolic activation of procarcinogens by subcellular enzyme fractions in the C3H 10T1/2 and BALB/c 3T3 cell transformation systems.
    Schechtman LM
    IARC Sci Publ; 1985; 67():137-62. PubMed ID: 3913640
    [No Abstract]   [Full Text] [Related]  

  • 2. Study of the ability of phenacetin, acetaminophen, and aspirin to induce cytotoxicity, mutation, and morphological transformation in C3H/10T1/2 clone 8 mouse embryo cells.
    Patierno SR; Lehman NL; Henderson BE; Landolph JR
    Cancer Res; 1989 Feb; 49(4):1038-44. PubMed ID: 2912548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of chemically induced multistep neoplastic transformation in C3H 10T 1/2 cells.
    Landolph JR
    Carcinog Compr Surv; 1985; 10():211-23. PubMed ID: 4064004
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutagenicity of the dihydrodiols and bay-region diol-epoxides of benzo(c)phenanthrene in bacterial and mammalian cells.
    Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Croisy-Delcey M; Ittah Y; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1980 Aug; 40(8 Pt 1):2876-83. PubMed ID: 6992991
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutagenicity of diol-epoxides and tetrahydroepoxides of benz(a)acridine and benz(c)acridine in bacteria and in mammalian cells.
    Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Lehr RE; Kumar S; Schaefer-Ridder M; Engelhardt U; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1983 Apr; 43(4):1656-62. PubMed ID: 6339041
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of liver cell cultures in mutagenesis studies.
    Huberman E; Jones CA
    Ann N Y Acad Sci; 1980; 349():264-72. PubMed ID: 6784635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative studies on metabolic activation in vitro employing benzo[a]pyrene as the test compound.
    Doolittle DJ; Newton JF; Goodman JI
    Mutat Res; 1983 Mar; 108(1-3):29-44. PubMed ID: 6300667
    [No Abstract]   [Full Text] [Related]  

  • 8. Recommendations for experimental protocols and for scoring transformed foci in BALB/c 3T3 and C3H 10T1/2 cell transformation.
    IARC Sci Publ; 1985; 67():205-19. PubMed ID: 3830890
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutagenicity and tumor-initiating activity of cyclopenta(c,d)pyrene and structurally related compounds.
    Wood AW; Levin W; Chang RL; Huang MT; Ryan DE; Thomas PE; Lehr RE; Kumar S; Koreeda M; Akagi H; Ittah Y; Dansette P; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1980 Mar; 40(3):642-9. PubMed ID: 7471084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gene mutation induction by benz(a)pyrene following metabolic activation].
    Pashin IuV; Bakhitova LM
    Biull Eksp Biol Med; 1981 Sep; 92(9):327-9. PubMed ID: 6271305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased production of mutagenic metabolites of carcinogens by tissues from senescent rodents.
    Baird MB; Birnbaum LS
    Cancer Res; 1979 Nov; 39(11):4752-5. PubMed ID: 498103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity study of butachlor and its metabolites using Salmonella typhimurium.
    Hsu KY; Lin HJ; Lin JK; Kuo WS; Ou YH
    J Microbiol Immunol Infect; 2005 Dec; 38(6):409-16. PubMed ID: 16341341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of glutathione and uridine 5'-diphosphoglucuronic acid on benzo(a)pyrene mutagenesis in the Salmonella/microsome assay.
    Malaveille C; Brun G; Hautefeuille A; Bartsch H
    Dev Toxicol Environ Sci; 1980; 8():175-80. PubMed ID: 6273102
    [No Abstract]   [Full Text] [Related]  

  • 14. Contributions of two inducible forms of cytochrome P-450 in rat liver microsomes to the metabolic activation of various chemical carcinogens.
    Kawajiri K; Yonekawa H; Gotoh O; Watanabe J; Igarashi S; Tagashira Y
    Cancer Res; 1983 Feb; 43(2):819-23. PubMed ID: 6401224
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic inactivation of mutagenic benzo(a)pyrene metabolites: significance to carcinogenicity and implications for in vitro tests.
    Glatt HR; Platt KL; Vogel K; Bücker M; Billings R; Oesch F
    Dev Toxicol Environ Sci; 1980; 8():181-6. PubMed ID: 6273103
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of cytotoxicity, mutation, cytogenetic changes, and neoplastic transformation by benzo(a)pyrene and derivatives in C3H/10T1/2 clone 8 mouse fibroblasts.
    Gehly EB; Landolph JR; Heidelberger C; Nagasawa H; Little JB
    Cancer Res; 1982 May; 42(5):1866-75. PubMed ID: 6279286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro metabolic activation in genotoxicity assays with mammalian cell cultures.
    Belvedere G
    Boll Chim Farm; 1985 Feb; 124(2):57-68. PubMed ID: 4015867
    [No Abstract]   [Full Text] [Related]  

  • 18. Bovine bladder urothelial cell activation of carcinogens to metabolites mutagenic to Chinese hamster V79 cells and Salmonella typhimurium.
    Oglesby LA; Hix C; Snow L; MacNair P; Seig M; Langenbach R
    Cancer Res; 1983 Nov; 43(11):5194-9. PubMed ID: 6352016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prospects for the use of short-term tests in primary cancer prevention].
    Khudoleĭ VV; Pliss GB
    Vopr Onkol; 1984; 30(8):3-12. PubMed ID: 6385476
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition and enhancement of oncogenic cell transformation in C3H 10T 1/2 CL8 cells.
    Nesnow S; Garland H; Curtis G
    Carcinog Compr Surv; 1985; 10():225-34. PubMed ID: 4064005
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.